Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
TNF Inhibitors
•
Dermatology
How do you approach management of patients with RA who have paradoxical eczematous reaction while on TNF inhibitor?
What alternative biologics would be preferred?
Related Questions
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Is it safe to use one TNF inhibitor (e.g., infliximab) in a patient who has had a severe allergic reaction to a different TNF inhibitor (e.g., adalimumab)?
Would you be hesitant to continue a TNF inhibitor in a patient with stable RA and a history of COPD, Cor Pulmonale, severe reduced RVEF, but LVEF 65%?
What biologics would you use in a patient with rheumatoid arthritis who developed multiple basal cell carcinomas requiring Mohs surgery while on a TNF-inhibitor and did not respond to rituximab?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
Do you always pursue testing for NOD2 mutations when you are suspecting a diagnosis of Blau syndrome?
How do you manage oral ulcers as a side effect from leflunomide?
How would you approach management of a patient with seropositive RA and UIP-ILD, with concern for active lung disease?
Do you generally utilize calcium channel blockers on an as needed basis for patients with Raynaud's phenomenon?
How do you approach the use of immunosuppressive therapy in patients with rheumatoid arthritis and underlying immunodeficiency, such as IgA deficiency?